| 标题 |
Effectiveness and Safety of Polatuzumab Vedotin Plus an Anti-CD20 Monoclonal Antibody (Rituximab or Obinutuzumab) and Zanubrutinib in Relapsed/Refractory Diffuse Large B-Cell Lymphoma |
| 网址 | |
| DOI | |
| 其它 |
期刊:Cancer Med 作者:Zhang Y, Ren Y, Zhuang J, Yuan L, Wang Z, Zhang X, Wang W, Cheng Z, Cheng L, Li J, Liu P 出版日期:2025-08-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)